Acadia Pharmaceuticals buy Morgan Stanley
Start price
12.07.24
/
50%
€16.27
Target price
12.07.25
€25.68
Performance (%)
0.25%
Price
19.07.24
€16.31
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley for Acadia Pharmaceuticals is nearly unchanged. This prediction currently runs until 12.07.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Acadia Pharmaceuticals | 0.123% |
iShares Core DAX® | -3.033% |
iShares Nasdaq 100 | -3.554% |
iShares Nikkei 225® | -3.938% |
iShares S&P 500 | -1.517% |
Comments by Morgan_Stanley for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Morgan Stanley from $30.00 to $28.00. They now have an "overweight" rating on the stock.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by Morgan_Stanley for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€17.30
18.03.24
18.03.24
€27.59
18.03.25
18.03.25
-5.72%
19.07.24
19.07.24
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€27.40
19.12.23
19.12.23
€36.48
19.12.24
19.12.24
-40.47%
19.07.24
19.07.24